| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2023 | OFIX Orthofix Medical Inc. | Kenny Kevin J. | President Of Global Spine | Sell | 8,243 | $19.00 | $156,617.00 | -2.8% | +2.9% | -21.0% | |
| May 25, 2023 | CTSO Cytosorbents Corp | Bloch Kathleen P. | Interim CFO | Buy | 3,300 | $2.85 | $9,389.38 | +2.5% | -5.3% | -68.2% | |
| May 25, 2023 | BMRA Biomerica Inc | Irani Zackary S. | Chief Executive Officer | Buy | 700 | $1.59 | $1,115.00 | - | -27.5% | -59.1% | |
| May 25, 2023 | MASI Masimo Corp | Kiani Joe E74 | CEO And Chairman Of The Board | Buy | 6,365 | $157.16 | $1,000,342.47 | +0.6% | -30.0% | -19.6% | |
| May 25, 2023 | ZOMDF Zomedica Corp. | Powers Johnny D | Director | Buy | 100,000 | $0.19 | $19,340.00 | +6.7% | - | - | |
| May 25, 2023 | BVS Bioventus Inc. | Hawkins William A | Director | Buy | 88,000 | $2.68 | $235,567.20 | +37.2% | +50.2% | +142.2% | |
| May 25, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 20,000 | $22.24 | $444,700.00 | -3.5% | -49.7% | -3.0% | |
| May 24, 2023 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 2,500 | $2.31 | $5,768.25 | -0.8% | -58.3% | -83.6% | |
| May 24, 2023 | DXR Daxor Corp | Feldschuh Michael Richard75 | CEO &President | Buy | 2,000 | $9.75 | $19,500.00 | +1.3% | -0.8% | +0.1% | |
| May 24, 2023 | BFLY Butterfly Network, Inc. | Weiss Lawrence T69 | CLO, GC And Corp Sec | Sell | 52,296 | $2.22 | $116,076.20 | -4.0% | -18.7% | -54.2% | |
| May 24, 2023 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | Executive Chair | Sell | 45,660 | $1.44 | $65,873.68 | -11.1% | -35.6% | -11.0% | |
| May 24, 2023 | STIM Neuronetics, Inc. | Bakewell John K | Director | Sell | 14,400 | $2.70 | $38,880.00 | -15.6% | -41.4% | -17.3% | |
| May 24, 2023 | CERS Cerus Corp | Schulze Gail | Director | Buy | 9,850 | $2.03 | $19,980.73 | +13.4% | -15.8% | -8.9% | |
| May 24, 2023 | DXR Daxor Corp | Goudie Joy S. | Director | Buy | 300 | $9.75 | $2,925.00 | New | -0.8% | +0.1% | |
| May 24, 2023 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,000 | $7.76 | $23,280.00 | -2.7% | +1.5% | -25.3% | |
| May 24, 2023 | EW Edwards Lifesciences Corp | Wood Larry L67 | Global President Tavr &Surg | Sell | 6,421 | $84.23 | $540,840.83 | -2.9% | -9.4% | +4.3% | |
| May 24, 2023 | NXGL Nexgel, Inc. | Henry Scott Robert72 | Director | Buy | 7,000 | $1.96 | $13,720.00 | +2.7% | +0.5% | +12.7% | |
| May 23, 2023 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Technology Officer | Sell | 10,000 | $10.02 | $100,200.00 | -1.1% | -28.9% | -32.4% | |
| May 23, 2023 | UFPT Ufp Technologies Inc | Feldmann Cynthia L55 | Director | Sell | 2,056 | $153.97 | $316,564.40 | -12.7% | +7.3% | +64.1% | |
| May 23, 2023 | BVS Bioventus Inc. | Bihl Anthony P III | Interim CEO | Buy | 125,000 | $2.33 | $290,987.50 | New | +65.6% | +159.3% | |
| May 23, 2023 | PODD Insulet Corp | Minogue Michael R | Director | Buy | 3,300 | $304.75 | $1,005,675.00 | +37.0% | -33.7% | -38.9% | |
| May 23, 2023 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 60,000 | $10.12 | $607,200.00 | -14.0% | -28.9% | -32.4% | |
| May 23, 2023 | CERS Cerus Corp | Bjerkholt Eric71 | Director | Buy | 5,000 | $2.00 | $10,000.00 | +6.5% | -12.4% | -0.5% | |
| May 23, 2023 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $118.65 | $48,883.80 | -0.3% | -9.5% | +12.8% | |
| May 23, 2023 | AXGN Axogen, Inc. | Freitag Gregory Gene68 | Director | Sell | 7,468 | $9.23 | $68,899.16 | -1.1% | -34.9% | -32.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.